Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P15088 (
mast cell
)
14,925
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of an amino acid L-glutamine on aspirin-induced gastric lesions as well as on the
mast cell
population were studied in rats. L-glutamine had a pronounced inhibitory effect on gastric lesions produced by oral aspirin administration. Aspirin-induced increase in the
mast cell
population of the stomach was also prevented.
Parenteral
administration of aspirain did not produce any significant damage to the gastric mucosa.
...
PMID:Inhibition of mast cell population by L-glutamine in aspirin-induced ulceration in rat stomach. 61 89
A 68-year-old man presented with a 6-month history of fatigue, rhinorrhoea, pruritic skin lesions, left pleural effusion, ascites, oedema and weight loss of 10 kg. Investigations revealed hepatosplenomegaly, retroperitoneal lymphadenopathy, anaemia, leucocytosis with eosinophilia, hypoprothrombinaemia, hypocholesterolaemia and elevation of both gamma glutamyltransferase and alkaline phosphatase. Biopsies of a skin lesion, bone marrow and liver revealed
mast cell
infiltration, allowing the diagnosis of systemic mastocytosis (SM).
Hydroxyzine
plus ranitidine were given without success.
Hydroxyzine
treatment was stopped, and ketotifen was initiated; substantial symptomatic improvement was observed within 8 d. This case report indicates the effectiveness of ketotifen in the symptomatic treatment of SM.
...
PMID:A case of systemic mastocytosis; therapeutic efficacy of ketotifen. 204 Aug 76
Urticaria, after ingesting ethanol, is rare. A 36-year-old Caucasian male developed multiple, generalized, pruritic urticarial lesions 5 to 15 minutes after drinking alcoholic beverages of any type. A blinded challenge with 5 mL of chemically pure 95% ethanol in concentrated grape juice caused urticaria and an elevation of plasma histamine. Pure grape juice alone was unreactive. Prick skin tests with Brewers' yeast, ethanol, acetaldehyde, and acetic acid were negative.
Hydroxyzine
(25 mg, p.o., q.i.d.), given for three days prior to challenge, inhibited skin response and histamine release. Biopsy of the urticarial lesions caused by ethanol ingestion showed
mast cell
degranulation. In this subject, ethanol appeared to directly affect
mast cell
mediator release by non-IgE mechanisms.
...
PMID:Ethanol-induced urticaria: a case report. 338 58
The efficacy, safety and mechanisms of penicillin desensitization were studied in 24 adults and two children with serious infections that required therapy with a beta-lactam drug. Indications for desensitization included debilitating as well as life-endangering infections. Increasing oral doses of phenoxymethyl penicillin were administered at 15-minute intervals to a cumulative dose of 1.3 million units.
Parenteral
therapy with the beta-lactam drug of choice was instituted at that point. Immunologic complications of desensitization or therapy, ranging from pruritus to serum sickness, occurred in 12 patients. The appearance of gradually worsening wheezing led to abandonment of the procedure in one subject with cystic fibrosis and severe pulmonary disease. The remaining 25 patients were successfully desensitized and received full-dose parenteral therapy. Chronic desensitization was maintained in seven individuals with twice daily oral penicillins for 3 weeks to more than 2 years. No allergic complications of chronic desensitization or recurrent full-dose parenteral therapy were detected. Skin test reactions to one or all penicillin determinants became negative in 11 of 15 patients retested after acute desensitization. Two desensitized patients became skin test negative, remained skin test negative after cessation of desensitization, and tolerated subsequent beta-lactam therapy without allergic reactions or resensitization. The results of this study provide new evidence that acute and chronic penicillin desensitization is useful and an acceptably safe approach and suggest that antigen-specific
mast cell
desensitization contributes to the protection against anaphylaxis.
...
PMID:Acute and chronic desensitization of penicillin-allergic patients using oral penicillin. 381 32
Mast cells and histamine are present throughout the rat gastrointestinal system. Typical mast cells, differentiated from atypical mast cells by morphology, staining characteristics, and response to Compound 48/80, were the only
mast cell
type identified by histology in the cheek, tongue, esophagus, and nonglandular stomach. Atypical mast cells were found in large numbers in the glandular stomach, small and large intestine, and cecum, where they outnumbered typical mast cells by up to 20:1. Gastrointestinal histamine levels varied from 2.6 to 19.3 ng/mg in all tissues surveyed except for the glandular stomach, which contained 26 ng/mg. The amount of histamine per typical
mast cell
was estimated to be approximately 1.29 picograms; atypical mast cells contained less than 0.15 picograms per cell.
Parenteral
administration of Compound 48/80 resulted in the degranulation of typical mast cells, but not atypical mast cells, as determined by a fall both in typical
mast cell
number and a decrease in tissue histamine in areas rich in typical mast cells. These results indicate that striking regional differences in
mast cell
distribution and tissue histamine levels exist in the rat gastrointestinal system.
...
PMID:Typical and atypical mast cells of the rat gastrointestinal system: distribution and correlation with tissue histamine. 670 6
Sympathomimetic bronchodilators relax bronchial smooth muscle via stimulation of the enzyme adenylcyclase. Furthermore, they stabilize the membrane of the bronchial
mast cell
. Therefore, they are used in the treatment of acute asthma as well as in long-term prophylaxis. A new generation of beta 2-receptor binding derivates of isoproterenol offers increased therapeutic safety because of a reduced risk of cardiovascular side effects. Three routes of medication are available.
Parenteral
therapy is reserved for the treatment of acute severe asthma. The oral route can be used for long-term medication in smaller children. Mist therapy offers the advantage of topic medication. Efficient handling of a metered-dose aerosol is beyond the capabilities of small children; these patients get their topic treatment by nebulized solutions. The relevant data of clinical pharmacology are summarized for all forms of medication. Focusing on the role of sympathomimetic drugs, a medication strategy for the treatment of acute asthma as well as for long-term prophylaxis is described.
...
PMID:[Sympathomimetic drugs in the treatment of childhood asthma]. 714 59
Hydroxyzine
is a piperazine, tricyclic, H1-receptor antagonist with unique properties, especially the inhibition of
mast cell
and neuronal secretion. Preliminary results indicate is has an unusual ability to reduce interstitial cystitis symptoms. The long history, lack of major side effects, wide availability, low cost, and apparent effectiveness of hydroxyzine compel presentation of these preliminary results.
...
PMID:Hydroxyzine in the treatment of interstitial cystitis. 828 34
Experimental allergic encephalomyelitis (EAE) has been used as an animal model for the human demyelinating disease multiple sclerosis (MS). In acute MS or EAE, early disruption in the integrity of the blood-brain-barrier (BBB) precedes brain infiltration by inflammatory cells or any clinical evidence of disease. BBB permeability could be affected by vasoactive mediators and cytokines released from perivascular brain mast cells. We investigated the number and degree of activation of brain mast cells in EAE and the effect of the heterocyclic histamine-1 receptor antagonist hydroxyzine, a piperazine compound known to also block mast cells. Acute EAE was induced in Lewis rats by immunization with whole guinea pig spinal cord homogenate and complete Freund's adjuvant (CFA). A second group of animals were treated orally with hydroxyzine for one day before immunization and then continuously for 14 days. Control rats were treated with CFA or hydroxyzine alone. The clinical progression of EAE was assessed on days 10, 12 and 14 after immunization. The number of metachromatic mast cells and the degree of degranulation was assessed in the thalamus with light microscopy. At day 14, there was a three-fold increase in the number of brain mast cells with EAE, as compared to controls. These cells were positive for the immunoglobulin E binding protein (FcepsilonRI), while those from control rats were not. Over 40% of all thalamic mast cells studied in EAE showed partial staining or extruded secretory granule indicative of secretion.
Hydroxyzine
treatment inhibited (p<0.05) the progression and severity of EAE by 50% and the extent of
mast cell
degranulation by 70% (p<0.05). These findings indicate that brain mast cells are associated with EAE development and that inhibition of their activation correlates positively with the clinical outcome.
...
PMID:Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation. 1088 88